These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 11429029)

  • 21. Hepatitis C virus recurrence and immunosuppression-free state after liver transplantation.
    Manzia TM; Angelico R; Toti L; Lai Q; Ciano P; Angelico M; Tisone G
    Expert Rev Clin Immunol; 2012 Sep; 8(7):635-44. PubMed ID: 23078061
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Natural history of recurrent hepatitis C.
    Berenguer M
    Liver Transpl; 2002 Oct; 8(10 Suppl 1):S14-8. PubMed ID: 12362293
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Consensus guidelines for the management of hepatitis C infection.
    Consensus Guidelines Committee for the Management of Hepatitis C Infection
    Saudi Med J; 2003 Jul; 24 Suppl 2():S99-118. PubMed ID: 25121186
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evolution of hepatitis C virus in liver allografts.
    Demetris AJ
    Liver Transpl; 2009 Nov; 15 Suppl 2():S35-41. PubMed ID: 19876940
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Management of hepatitis C virus infection in liver transplantation].
    Berenguer M
    Gastroenterol Hepatol; 2006; 29(7):422-7. PubMed ID: 16938259
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hepatitis B virus and hepatitis C virus treatment and management in patients receiving immune-modifying agents.
    Juan J; Feld JJ
    Curr Opin Rheumatol; 2014 Jul; 26(4):395-403. PubMed ID: 24841230
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antibody response to hepatitis C virus infection after liver transplantation.
    Hsu HH; Wright TL; Tsao SC; Combs C; Donets M; Feinstone SM; Greenberg HB
    Am J Gastroenterol; 1994 Aug; 89(8):1169-74. PubMed ID: 7519818
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Control of hepatitis in the transplant patient: a journey begun--but not there yet.
    Rubin RH
    Transpl Infect Dis; 2000 Dec; 2(4):151-2. PubMed ID: 11429027
    [No Abstract]   [Full Text] [Related]  

  • 29. Recurrent hepatitis C genotype 1b following liver transplantation: treatment with combination interferon-ribavirin therapy.
    Berenguer M; Prieto M; Palau A; Carrasco D; Rayón JM; Calvo F; Berenguer J
    Eur J Gastroenterol Hepatol; 2004 Nov; 16(11):1207-12. PubMed ID: 15489583
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Adaptive cell immune response against the hepatitis C virus infection].
    Rallón NI; Soriano V; Benito JM
    Med Clin (Barc); 2007 Oct; 129(12):469-76. PubMed ID: 17953913
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Role of host in spontaneous recovery from viral hepatitis C: the body's condition at the moment of infection].
    Isaguliants MG; Ozeretskovskaia NN; Znoĭko OO; Tsyganova EV
    Vopr Virusol; 2008; 53(2):4-9. PubMed ID: 18450102
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Treatment for recurrent hepatitis C virus infection after liver transplantation.
    Balbi E; Leal CR; Pacheco-Moreira LF; Pousa FS; Covelo MC; Gonzalez AC; Oliveira PV; Agoglia L; Roma J; Cariús LP; Enne M
    Transplant Proc; 2009 Apr; 41(3):891-4. PubMed ID: 19376381
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pathogenesis of hepatitis C virus recurrence in the liver allograft.
    McCaughan GW; Zekry A
    Liver Transpl; 2002 Oct; 8(10 Suppl 1):S7-S13. PubMed ID: 12362292
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Successful combination of direct antiviral agents in liver-transplanted patients with recurrent hepatitis C virus.
    Rupp C; Hippchen T; Neuberger M; Sauer P; Pfeiffenberger J; Stremmel W; Gotthardt DN; Mehrabi A; Weiss KH
    World J Gastroenterol; 2018 Mar; 24(12):1353-1360. PubMed ID: 29599610
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Hepatitis C virus ten years after its discovery].
    Bralet MP; Dhumeaux D; Zafrani ES
    Ann Pathol; 1999 Dec; 19(6):499-512. PubMed ID: 10617807
    [No Abstract]   [Full Text] [Related]  

  • 36. Sofosbuvir and simeprevir without ribavirin effectively treat hepatitis C virus genotype 1 infection after liver transplantation in a two-center experience.
    Jackson WE; Hanouneh M; Apfel T; Alkhouri N; John BV; Zervos X; Zein NN; Hanouneh IA
    Clin Transplant; 2016 Jun; 30(6):709-13. PubMed ID: 27019204
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Natural history of hepatitis C virus infection: from chronic hepatitis to cirrhosis, to hepatocellular carcinoma.
    Leone N; Rizzetto M
    Minerva Gastroenterol Dietol; 2005 Mar; 51(1):31-46. PubMed ID: 15756144
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunogenetic studies of the hepatitis C virus infection in an era of pan-genotype antiviral therapies - Effective treatment is coming.
    Ellwanger JH; Kaminski VL; Valverde-Villegas JM; Simon D; Lunge VR; Chies JAB
    Infect Genet Evol; 2018 Dec; 66():376-391. PubMed ID: 28811194
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Association of multispecific CD4(+) response to hepatitis C and severity of recurrence after liver transplantation.
    Rosen HR; Hinrichs DJ; Gretch DR; Koziel MJ; Chou S; Houghton M; Rabkin J; Corless CL; Bouwer HG
    Gastroenterology; 1999 Oct; 117(4):926-32. PubMed ID: 10500076
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Recurrent hepatitis C after liver transplantation.
    Teixeira R; Pastacaldi S; Papatheodoridis GV; Burroughs AK
    J Med Virol; 2000 Aug; 61(4):443-54. PubMed ID: 10897062
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.